David D. Christ - Concepedia

Author

David D. Christ

Also Known As

Christ, D.D., D D Christ, D. Christ, D. D. CHRIST, D. D. Christ, D.D. Christ, David Christ, David D Christ, David D. Christ, David D. Christ

Publications

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)DuPont (United States)Wilmington University Experimental Station Bristol-Myers Squibb (Germany)

About

David D. Christ is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	26	1.3K
2	Biochemistry	16	20	1.1K
3	Natural Sciences	14	15	906
4	Health Sciences	2	2	117
5	Biomolecular Engineering	1	1	79

David D. Christ

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane. J G Kenna, Hiroaki Satoh, David D. Christ, Journal of Pharmacology and Experimental Therapeutics	1988	211
Identification and Characterization of Efavirenz Metabolites by Liquid Chromatography/Mass Spectrometry and High Field NMR: Species Differences in the Metabolism of Efavirenz Abdul Mutlib, Hua Chen, Gregory A. Nemeth, Drug Metabolism and Disposition	1999	141
Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase. Hiroaki Satoh, Brian M. Martin, A H Schulick, Proceedings of the National Academy of Sciences ImmunologyHalothane-treated RatsPathologyToxicological MechanismMedicinal Chemistry	1989	137
Discovery of γ-Lactam Hydroxamic Acids as Selective Inhibitors of Tumor Necrosis Factor α Converting Enzyme: Design, Synthesis, and Structure−Activity Relationships James J.‐W. Duan, Lihua Chen, Zelda R. Wasserman, Journal of Medicinal Chemistry	2002	119
Enflurane Metabolism Produces Covalently Bound Liver Adducts Recognized by Antibodies from Patients with Halothane Hepatitis David D. Christ, J G Kenna, William Hammerer, Anesthesiology ImmunologyHalothane-treated RatsPathologyCirrhosisAutoimmune Liver Disease	1988	115
4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2,4-dichlorophenyl)pyrazolo[1,5-<i>a</i>]-1,3,5-triazine: A Potent, Orally Bioavailable CRF<sub>1</sub> Receptor Antagonist Liqi He, Paul J. Gilligan, Robert Zaczek, Journal of Medicinal Chemistry Receptor AntagonistPharmacotherapyPharmaceutical ChemistryMolecular PharmacologyMedicinal Chemistry	2000	113
The Species-Dependent Metabolism of Efavirenz Produces a Nephrotoxic Glutathione Conjugate in Rats Abdul Mutlib, Ronald J. Gerson, Paul C. Meunier, Toxicology and Applied Pharmacology Reductive StressMolecular PharmacologyBiochemistryMedicineLiver Physiology	2000	105
Sultam Hydroxamates as Novel Matrix Metalloproteinase Inhibitors Robert J. Cherney, Ruowei Mo, Dayton T. Meyer, Journal of Medicinal Chemistry Medicinal ChemistryPharmaceutical ScienceCompound 26BiochemistryMedicine	2004	94
Potent, Orally Bioavailable Delta Opioid Receptor Agonists for the Treatment of Pain: Discovery of<i>N</i>,<i>N</i>-Diethyl-4-(5-hydroxyspiro[chromene-2,4′-piperidine]-4-yl)benzamide (ADL5859) Bertrand Le Bourdonnec, Rolf T. Windh, Christopher W. Ajello, Journal of Medicinal Chemistry	2008	89
The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine: A corticotropin-releasing factor (hCRF1) antagonist Paul J. Gilligan, Caryn Baldauf, Anthony J. Cocuzza, Bioorganic & Medicinal Chemistry	2000	83

Page 1